|
gptkbp:instanceOf
|
gptkb:synthetic_anabolic_steroid
|
|
gptkbp:administeredBy
|
oral route
|
|
gptkbp:alsoKnownAs
|
gptkb:Anavar
|
|
gptkbp:ATCCode
|
A14AA08
|
|
gptkbp:brand
|
gptkb:Anavar
gptkb:Lonavar
gptkb:Oxandrin
Protivar
|
|
gptkbp:CASNumber
|
53-39-4
|
|
gptkbp:chemicalFormula
|
C19H30O3
|
|
gptkbp:developedBy
|
gptkb:Searle_Laboratories
|
|
gptkbp:eliminationHalfLife
|
9 hours
|
|
gptkbp:introducedIn
|
1964
|
|
gptkbp:legalStatus
|
gptkb:Schedule_III_controlled_substance_(US)
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
306.44 g/mol
|
|
gptkbp:notableDerivative
|
gptkb:dihydrotestosterone_(DHT)
|
|
gptkbp:notableFor
|
high anabolic activity
low androgenic activity
|
|
gptkbp:pregnancyCategory
|
gptkb:X_(US)
|
|
gptkbp:prohibits
|
sports by WADA
|
|
gptkbp:PubChem_CID
|
5878
|
|
gptkbp:sideEffect
|
hair loss
acne
liver toxicity
virilization in women
changes in libido
|
|
gptkbp:UNII
|
J925LBJ8VP
|
|
gptkbp:usedFor
|
counteracting protein catabolism
promoting weight gain
treating muscle wasting
treating osteoporosis
treating severe burns
|
|
gptkbp:bfsParent
|
gptkb:anabolic_steroids
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
oxandrolone
|